Order Article Reprints

Scuteri D, Cassano R, Trombino S, Russo R, Mizoguchi H, Watanabe C, Hamamura K, Katsuyama S, Komatsu T, Morrone LA, et al. Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia. Pharmaceutics. 2021; 13(3):379. https://doi.org/10.3390/pharmaceutics13030379

Scuteri, Damiana, Roberta Cassano, Sonia Trombino, Rossella Russo, Hirokazu Mizoguchi, Chizuko Watanabe, Kengo Hamamura, Soh Katsuyama, Takaaki Komatsu, Luigi Antonio Morrone, and et al. 2021. "Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia" Pharmaceutics 13, no. 3: 379. https://doi.org/10.3390/pharmaceutics13030379

Scuteri, D., Cassano, R., Trombino, S., Russo, R., Mizoguchi, H., Watanabe, C., Hamamura, K., Katsuyama, S., Komatsu, T., Morrone, L. A., Rombolà, L., Adornetto, A., Laganà, A. S., Corasaniti, M. T., Tonin, P., Sakurada, S., Sakurada, T., Nicotera, P., & Bagetta, G. (2021). Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia. Pharmaceutics, 13(3), 379. https://doi.org/10.3390/pharmaceutics13030379